作者
Stefan Blankenberg,Moritz Seiffert,Reinhard Vonthein,Helmut Baumgartner,Sabine Bleiziffer,Michael A. Borger,Yeong‐Hoon Choi,Peter Clemmensen,Jochen Cremer,Martin Czerny,Nina Diercks,Ingo Eitel,Stephan Ensminger,Derk Frank,Norbert Frey,Andreas Hagendorff,Christian Hagl,Christian W. Hamm,Utz Kappert,Matthias Karck,Won‐Keun Kim,Inke R. König,Markus Krane,Ulf Landmesser,Axel Linke,Lars S. Maier,Steffen Maßberg,Franz‐Josef Neumann,Hermann Reichenspurner,Tanja K. Rudolph,Çhristof Schmid,Holger Thiele,Raphael Twerenbold,Thomas Walther,Dirk Westermann,Erion Xhepa,Andreas Ziegler,Volkmar Falk
摘要
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking on the appropriate treatment strategy in routine clinical practice.